Mamoor, S. (2025). Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: SLC1A1. Zenodo.
Chicago (17e ed.) BronvermeldingMamoor, Shahan. Therapeutic Targeting in HER2+ Breast Cancer to Prevent and Treat CNS Disease: SLC1A1. Zenodo, 2025.
MLA (9e ed.) BronvermeldingMamoor, Shahan. Therapeutic Targeting in HER2+ Breast Cancer to Prevent and Treat CNS Disease: SLC1A1. Zenodo, 2025.
Let op: Deze citaties zijn niet altijd 100% accuraat.